Today: 21 May 2026
Browse Category

NASDAQ:QBTS 19 September 2025 - 5 November 2025

IonQ’s Big Surge – Are Quantum Computing Stocks Just Another Bubble?

IonQ’s Big Surge – Are Quantum Computing Stocks Just Another Bubble?

IonQ shares have surged about 300% in the past year, outpacing other quantum computing stocks amid soaring sector valuations and bullish Wall Street targets. IonQ’s Q2 2025 revenue hit $20.7 million, up 15% over guidance, with full-year guidance raised to $82–100 million. The company now trades at roughly 300 times trailing sales. Analysts warn of bubble-like conditions as the sector’s market cap exceeds $40 billion.
Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

D-Wave’s share price surged nearly 3,000% in the past year, peaking at $46.75 on Oct. 15 before dropping to $27.30 and rebounding to $31.06 after reports of possible U.S. government equity deals with quantum firms. The company announced a €10 million sale of its Advantage2 system in Europe and posted first-half 2025 revenue of $18 million against a Q2 GAAP loss of $167 million. Trading volumes remain extremely high.
IonQ vs Rigetti Computing vs D-Wave Quantum Stocks on October 23, 2025

IonQ vs Rigetti Computing vs D-Wave Quantum Stocks on October 23, 2025

Shares of IonQ, Rigetti, and D-Wave jumped up to 16% in early trading Oct. 22 after reports the U.S. Commerce Department may take equity stakes in the firms. Prices eased after officials denied any current negotiations. At Thursday’s close, IonQ rose 7% to $59.40, Rigetti 9.8% to $39.60, and D-Wave 13.8% to $31.06, all sharply higher year-over-year.
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Gold Rush: D-Wave (QBTS) Stock Skyrockets 3,000% — Is the Rally Sustainable?

D-Wave’s QBTS stock closed at $27.29 on Oct. 22, down 15% for the day and about 35% below its Oct. 15 peak of $46.75. The stock is still up roughly 300% year-to-date, despite heavy volatility. Market cap reached as high as $14 billion, far above its $18 million in H1 2025 revenue. Analyst targets range from $20 to $50, with several firms warning of sharp swings and high valuation.
Quantum Rivals Clash: D-Wave vs Rigetti – Which Stock Will Skyrocket in 2026?

Quantum Rivals Clash: D-Wave vs Rigetti – Which Stock Will Skyrocket in 2026?

D-Wave reported Q2 FY2025 revenue of $3.1 million, up 42% year-over-year, but posted a GAAP net loss of $167.3 million, mainly from non-cash warrant charges. The company ended the quarter with $819 million in cash after a $400 million equity raise. Rigetti’s Q2 revenue reached $1.8 million with a $39.7 million net loss and $572 million in cash. Both firms trade at price/sales ratios in the hundreds or higher despite low sales.
Quantum Gold Rush: Inside D-Wave (QBTS) Stock’s 2600% Surge – Hype or Game-Changer?

Quantum Gold Rush: Inside D-Wave (QBTS) Stock’s 2600% Surge – Hype or Game-Changer?

D-Wave Quantum shares soared to all-time highs near $33 in early October 2025, up over 3,000% from a year ago, pushing its market cap to $10–11 billion—about 400 times annual revenue. Q2 revenue reached $3.1 million while net loss hit $167 million. Technical breakthroughs and partnerships fueled the rally, but analysts warn the surge may be unsustainable. Trading remains volatile, with record volumes and heavy options activity.
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Leap or Overhyped Rally? D-Wave Quantum (QBTS) Stock Soars in 2025

D-Wave Quantum shares have jumped over 200% in 2025 and more than 2,000% in the past year, hitting record highs on heavy trading. The company’s market value neared $9.5 billion—over 400 times annual sales—despite a Q2 net loss of $167 million. D-Wave raised $400 million in mid-2025 and launched its new Advantage2 quantum computer. Partnerships include NASA JPL and Yonsei University.
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Computing Frenzy: D-Wave (QBTS) Stock Surges 289% in 2025 on Breakthrough Deals

QBTS closed at a record $32.5 on Oct. 3, up 289% year-to-date, after D-Wave announced $5.7M in new orders and reported strong pilot results with UK police. Volume surged to 77 million shares as technical indicators flashed overbought. Q2 revenue rose 42% to $3.1M, with a $819M cash balance after a $400M equity raise. Analysts forecast $24.8M in 2025 revenue; most rate the stock a Buy.
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Leap for Investors: D-Wave (QBTS) Stock Rockets Amid Breakthroughs, Big Cash & Booming Demand

QBTS closed up 11.5% at $28.57 on Oct 2, 2025, with nearly 19.8 million shares traded, nearing its 12-month high. The stock has surged from the mid-$18s since mid-September. D-Wave reported $3.1 million in Q2 revenue and ended the quarter with $819 million in cash after a $400 million share offering. Wall Street consensus remains “Buy,” with average 12-month targets of $20–23.
Global Markets on Edge as Fed Rate Decision Nears: Asia Optimistic, West Cautious

Quantum Gold Rush: QUBT vs. D-Wave – Inside the High-Stakes 2025 Quantum Computing Showdown

Quantum Computing Inc. launched a photonic chip foundry in Arizona in 2025 and secured NASA contracts for its Dirac-3 machine. D-Wave Quantum reported $8.8 million in 2024 revenue, a major 2025 system sale in Germany, and 42% YoY revenue growth in Q2 2025. Both stocks surged over 1,800%–3,000% in the past year, despite ongoing losses and multi-billion-dollar market caps.
Global Markets on Edge as Fed Rate Decision Nears: Asia Optimistic, West Cautious

Quantum Leap: Why IonQ, Rigetti, and D-Wave Stocks Are Soaring in a Tech Breakout

D-Wave Quantum shares jumped over 2,000% year-over-year, Rigetti rose 2,448%, and IonQ climbed 705%, as quantum computing stocks rally. IonQ hit record highs above $65 after major acquisitions and government deals. Rigetti rebounded with new contracts and a raised price target. D-Wave launched a 4,400-qubit system and reported 83% Asia-Pacific booking growth.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop